Mon, March 1, 2021
Fri, February 26, 2021
Thu, February 25, 2021
Wed, February 24, 2021
Tue, February 23, 2021
Mon, February 22, 2021
Sun, February 21, 2021
Fri, February 19, 2021

Geoffrey Porges Maintained (TBPH) at Buy with Increased Target to $41 on, Feb 24th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-41-on-feb-24th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Geoffrey Porges of SVB Leerink, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Increased Target from $35 to $41 on, Feb 24th, 2021.

Geoffrey has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Geoffrey's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Geoffrey


  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $31 on, Wednesday, December 16th, 2020
  • Liisa Bayko of "Evercore ISI Group" Initiated at Buy and Held Target at $30 on, Tuesday, November 24th, 2020

Publication Contributing Sources